HHS critical of “overprescribing” psychiatric medications to children
The Brown University Child & Adolescent Psychopharmacology Update · 2026-06 · 28 (6) · 5-6
DOI: 10.1002/cpu.31066 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Brown University Child & Adolescent Psychopharmacology Update, online erschienen am 02.06.2026. Verfasst von Alison Knopf.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
On May 4, the U.S. Department of Health and Human Services (HHS) announced efforts to “curb psychiatric overprescribing.” The announcement made at a Make America Healthy Again (MAHA) Institute summit on mental health and overmedicalization,” was made by closing speaker, HHS Secretary Robert F. Kennedy, Jr., in particular cited psychiatric medications to children. “Today, we take clear and decisive action to confront our nation's mental health crisis by addressing the overuse of psychiatric medications—especially among children,” he said. “We will support patient autonomy, require informed consent and shared decision‐making, and shift the standard of care toward prevention, transparency, and a more holistic approach to mental health.”
Zitieren
APA
Knopf, A. (2026). HHS critical of “overprescribing” psychiatric medications to children. The Brown University Child & Adolescent Psychopharmacology Update, 28(6), 5-6. https://doi.org/10.1002/cpu.31066
Vancouver
Knopf A. HHS critical of “overprescribing” psychiatric medications to children. The Brown University Child & Adolescent Psychopharmacology Update. 2026;28(6):5-6. doi:10.1002/cpu.31066
BibTeX
@article{Knopf2026,
author = {Knopf, Alison},
title = {HHS critical of “overprescribing” psychiatric medications to children},
journal = {The Brown University Child & Adolescent Psychopharmacology Update},
year = {2026},
volume = {28},
number = {6},
pages = {5--6},
doi = {10.1002/cpu.31066}
}
EUVIMED